Skye Bioscience, Inc. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
Skye Bioscience, Inc. (SKYE) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $1.91 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Shareholders' Equity
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2025-11-10
- Skye Bioscience, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-09-30 was $1.91M.
- Skye Bioscience, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-06-30 was $2.03M, a 11.19% increase year-over-year.
- Skye Bioscience, Inc. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2024-06-30 was $1.83M.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 month |
|---|---|---|
| 2025-09-30 | $1.91M 10-Q · filed 2025-11-10 | $3.95M derived: sum of 2 quarters · filed 2025-11-10 |
| 2025-06-30 | $2.03M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $1.83M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |